EYPT - EyePoint Pharmaceuticals, Inc.
13.62
-0.360 -2.643%
Share volume: 764,199
Last Updated: 05-12-2026
Measuring And Control Equipment/Lab Analytical Instruments:
-0.07%
PREVIOUS CLOSE
CHG
CHG%
$13.98
-0.36
-0.03%
View ratios
| Fiscal Date | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | 03-31-2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
| Report Date | 08-08-2024 | 11-07-2024 | 03-06-2025 | 05-08-2025 | 08-07-2025 | 11-06-2025 | 03-05-2026 | 05-07-2026 | |
| Total revenue | 9.477 M | 10.524 M | 11.588 M | 24.453 M | 5.333 M | 966.000 K | 619.000 K | 696.000 K | |
| Cost of revenue | 1.401 M | 736.000 K | -2.896 M | 0.000 | 0.000 | 0.000 | 2.066 M | 0.000 | |
| Gross profit | 8.076 M | 9.788 M | 14.484 M | 24.453 M | 5.333 M | 966.000 K | -1.447 M | 696.000 K | |
| 21.20% | 47.98% | 68.83% | -78.19% | -81.89% | -249.79% | 148.10% | |||
| Operating expenses | 42.572 M | 42.512 M | 55.960 M | 72.450 M | 67.360 M | 62.244 M | 70.595 M | 87.391 M | |
| Selling general and admin | 12.750 M | 12.970 M | 12.537 M | 13.876 M | 11.862 M | 14.490 M | 11.382 M | 15.243 M | |
| Research and development | 29.822 M | 29.542 M | 43.423 M | 58.574 M | 55.498 M | 47.754 M | 59.213 M | 72.148 M | |
| Total expenses | 42.622 M | 42.536 M | 59.723 M | 73.290 M | 67.560 M | 62.991 M | 68.898 M | 87.922 M | |
| -0.20% | 40.41% | 22.72% | -7.82% | -6.76% | 9.38% | 27.61% | |||
| Operating income | -34.546 M | -32.748 M | -45.239 M | -48.837 M | -62.227 M | -62.025 M | -70.345 M | -87.226 M | |
| Ebit | -30.826 M | -29.361 M | -41.295 M | -45.195 M | -59.333 M | -59.732 M | -67.390 M | -84.882 M | |
| Pretax income | -30.826 M | -29.361 M | -41.309 M | -45.195 M | -59.333 M | -59.732 M | -67.423 M | -84.882 M | |
| -4.75% | 40.69% | 9.41% | 31.28% | 0.67% | 12.88% | 25.89% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 93.000 K | 0.000 | 0.000 | -50.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -30.826 M | -29.361 M | -41.399 M | -45.195 M | -59.426 M | -59.732 M | -67.609 M | -84.832 M | |
| 4.75% | -41.00% | -9.17% | -31.49% | -0.51% | -13.19% | -25.47% |